Regenxbio (RGNX) Receivables - Other (2014 - 2025)

Regenxbio's Receivables - Other history runs 10 years deep, the most recent figure standing at $2.0 million for Q4 2025.

• In Q4 2025, Receivables - Other fell 82.33% year-over-year to $2.0 million; the TTM figure through Dec 2025 stood at $2.0 million (down 82.33% YoY), while the FY2025 annual figure was $2.0 million, down 82.33% from the prior year.
• Receivables - Other was $2.0 million for Q4 2025 at Regenxbio, down from $17.0 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $33.5 million in Q2 2022 to a low of $28000.0 in Q2 2025.
• Historically, Receivables - Other has averaged $8.1 million across 5 years, with a median of $2.0 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Receivables - Other jumped 8179.71% in 2021, then sank 99.71% in 2025.
• A 5-year view of Receivables - Other shows it stood at $1.1 million in 2021, then soared by 477.28% to $6.2 million in 2022, then decreased by 19.35% to $5.0 million in 2023, then surged by 126.0% to $11.3 million in 2024, then slumped by 82.33% to $2.0 million in 2025.
• The last three Receivables - Other figures came in at $2.0 million (Q4 2025), $17.0 million (Q3 2025), and $28000.0 (Q2 2025), per Business Quant data.